Biopharmaceutical classification of desloratadine – not all drugs are classified the easy way
Data publikacji: 16 sty 2020
Zakres stron: 131 - 144
Przyjęty: 31 maj 2019
DOI: https://doi.org/10.2478/acph-2020-0006
Słowa kluczowe
© 2020 Katja Berginc et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
The biopharmaceutical classification of drugs was designed as a basis for bio-waivers – a mechanism with the double ethical benefit of delivering new drug formulations to the market with less human testing and lower cost. However, many drugs defy simple classification because